When can legitimate goods be modified and resold using the original trade mark?
This article examines the legal principles of trade mark exhaustion and explores how brand owners can manage their reputation after goods have been sold.
Read more
The power of organoids – advances in disease modelling research
In March 2025, the first Cambridge Human Organoid Symposium took place at Jesus College, Cambridge. Having attended, trainee patent attorney Oliver Herd shares the latest research findings presented.
Read more
Targeting the undruggable proteome with molecular glues
Recent patent and clinical trial activity highlights a rising global interest in molecular glue research to improve patient outcomes for cancer, neurodegenerative, and autoimmune disease treatments.
Read more
Patent filings in treatments for neurodegenerative disorders: a shift toward biotherapeutic innovation
This article explores a major shift in global patent filings for neurodegenerative disorder therapies over the past decade. Once dominated by big pharma’s small molecules, innovation is now increasingly led by SMEs developing biotherapeutics targeting root causes. This trend reflects rising interest in precision medicine and suggests progress toward more effective treatments beyond symptom management.
Read more
The Greenshoots Podcast by Appleyard Lees – Inside Green Innovation: Progress Report – Nuclear
In this episode, join Partner and Patent Attorney, Adam Tindall along with Senior Associate and Patent Attorney, Matthew Bennett, as they discuss the current state of IP in the nuclear industry, interesting technology insights, and fusion and fission IP, as featured in their article as part of the Inside Green Innovation: Progress Report.
Read more
Optus v Apple – CoA increases FRAND licence to $500m ($700m with interest) in favour of Optus
In a judgment that further swings the pendulum back towards the UK being a 'SEP-owner-friendly' jurisdiction, the CoA has set the terms of the FRAND licence payable by Apple at a little over $700m ($500m + $200m interest).
Read more
IP audits – what are the benefits?
In this article, Senior Associate, Rachel Mercer, and Trainee Patent Attorney, Emma Lyons, explore the value of IP audits for businesses of all sizes. Discover how an audit can uncover hidden assets, support funding efforts, and strengthen your IP strategy. With the UKIPO’s updated ‘IP Advance’ scheme offering financial support to SMEs, now is an ideal time to assess and optimise your IP portfolio.
Read more
Patenting user-centric inventions in the UK is technically possible
In this article, we look at a recent UK case that illustrates how a user-centric invention that utilises hardware components, such as sensors and displays, can still fail to have an effect on a technical process. We also discuss how we can help you to determine whether a user-centric invention is likely to be patentable or not patentable in the UK.
Read more
Make way for the new EU design! EU design directive (2024/2823) and EU design regulation (2024/2822)
New EU design legislation, which came into force on 8 December 2024, will shortly start coming into effect. The legislation aims to modernise the EU design system, increase accessibility and strengthen EU design rights, reinforcing the value in design protection.
Read more
Patent Box – backdating and example calculation – part 5
Part 5 of our Patent Box article series discusses the Patent Box tax relief, specifically addressing the possibility of backdating claims, retrospective Patent Box claims, and how to calculate the Patent Box deduction for accounting periods from 1 April 2023, using an example to demonstrate how the tax reduction works.
Read more
Patent Box eligibility – patent jurisdiction and qualifying development – part 4
In part 4 of our Patent Box article series, we discuss the Patent Box tax relief in the UK, detailing the eligibility criteria for companies to reduce their Corporation Tax on profits from patented inventions.
Read more
